Articles From: iRobot To Host Analyst Day to ISSI Introduces Industry's Highest-Performance, Wide Voltage, Quad-Interface Dual Transfer Rate (DTR) Serial NOR Flash Memory


BEDFORD, Mass.
Sign-up for iRobot To Host Analyst Day investment picks
Infringing Robots Now Subject to Impound and Destruction Orders throughout Germany BEDFORD, Mass.
Sign-up for iRobot's Preliminary Injunctions Against Shenzhen Silver Star Affirmed on All Counts investment picks
2014/5/8
William Aisenberg, Finance & Apparel Industry Veteran, Joins as Chief Financial Officer Scott Furash, Apparel and Textile Veteran, Joins As Vice President Global Sourcing.
Sign-up for Ironclad Performance Wear adds Two Seasoned Executives to Team investment picks
Tom Felton, Global Apparel Industry Veteran, Joins as New Supply Chain Leader LOS ANGELES , May 21, 2014 /PRNewswire/ -- Ironclad Performance Wear Corporation (ICPW), the recognized leader in high-performance task-specific performance work gloves, announces today that Tom Felton has joined the Company as its Senior Vice President Supply Chain.
Sign-up for Ironclad Performance Wear Engages Senior Vice President, Supply Chain investment picks
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the Bank of America Merrill Lynch 2014 Healthcare Conference on Tuesday, May 13, 2014 at 3:40 p.m. Pacific Time/6:40 p.m. Eastern Time at the Encore at the Wynn in Las Vegas, NV.
Sign-up for Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Healthcare Conference investment picks
2014/5/12
BUENOS AIRES, Argentina , May 12, 2014 /PRNewswire/ -- IRSA Inversiones y Representaciones S.A. (NYSE: IRS; BASE: IRSA), the leading real estate company in Argentina , today announces its results for the first nine months of Fiscal Year 2014 Ended March 31, 2014 HIGHLIGHTS Net income attributable to the company's shareholders recorded a loss of Ps.
Sign-up for IRSA Inversiones y Representaciones S.A. Announces Results for the First nine months 2014 Ended March 31, 2014 investment picks
2011/01/27
Investors have lost more than $160 billion in structured and complex income investments, says John Wasik.
Sign-up for Is a Structured Product Good for Retirement Income? investment picks
2012/08/19
Readers weigh issues of money, accessibility, and proximity to friends and family when deciding whether to move to a smaller home.
Sign-up for Is Downsizing Part of Your Retirement Plan? investment picks
2011/03/20
Readers opine about rising premiums and the pros and cons of self-insuring.
Sign-up for Is Long-Term Care Insurance Right for You? investment picks
2008/11/06
This vehicle can lessen the impact of tax increases.
Sign-up for Is the Roth 401(k) Right for You? investment picks
2011/05/12
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/10/18
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/02/16
The essential first step for retirement portfolio planning: finding the right stock/bond mix.
Sign-up for Is Your Retirement Portfolio's Asset Allocation on Track? investment picks
2011/03/18
An estate-planning expert shares insights on who needs to take action--and who doesn't.
Sign-up for Is Your Wealth Safe Under New Estate Tax Laws? investment picks
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Earns $3.0 Million from GSK investment picks
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-PKK Rx investment picks
Greater than 2 percentage point reduction in HbA1c achieved after only 13 weeks of dosing CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c in Patients With Type 2 Diabetes investment picks
Seven-fold lower incidence of VTEs in patients treated with ISIS-FXIRx compared to enoxaparin CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx in the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery investment picks
CARLSBAD, Calif.
Sign-up for Isis Pharmaceuticals to Present at the UBS Global Healthcare Conference investment picks
Significant reductions of more than 1,500 mg/dL in triglycerides observed Significant reductions in chylomicrons observed CARLSBAD, Calif.
Sign-up for Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With Familial Chylomicronemia investment picks
2014/4/29
Results presented at the American Academy of Neurology meeting On track to initiate Phase 3 study in infants with SMA mid-year On track to initiate Phase 3 study in children with SMA in the second half of the year Isis to host an investor event and live webcast at 6:00 p.m. EDT on Tuesday, April 29 in Philadelphia CARLSBAD, Calif.
Sign-up for Isis Reports Updated Results from ISIS-SMN Rx Clinical Studies in Infants and Children with Spinal Muscular Atrophy investment picks
2014/4/29
BEIJING , April 29, 2014 /PRNewswire/ -- iSoftStone Holdings Limited (NYSE: ISS, "iSoftStone" or the "Company"), a leading China -based IT services provider, today announced that it has filed its annual report on Form 20-F for the year ended December 31, 2013 with the U.S. Securities and Exchange Commission.
Sign-up for iSoftStone's Annual Report for 2013 is Available Online investment picks
CHICAGO , May 12, 2014 /PRNewswire/ -- Telephone and Data Systems, Inc. (NYSE: TDS) announced today that Institutional Shareholder Services ("ISS"), Glass, Lewis & Co., LLC ("Glass Lewis") and Egan-Jones Proxy Services (" Egan -Jones"), the three major proxy advisory firms, are unanimous in their recommendation that TDS Common shareholders vote "FOR" the Company's nominees for the TDS Board of Directors.
Sign-up for ISS, Glass Lewis and Egan-Jones recommend TDS shareholders vote for TDS board nominees investment picks
MILPITAS, Calif., April 9, 2014 (GLOBE NEWSWIRE) -- Integrated Silicon Solution, Inc. (Nasdaq:ISSI) , a leader in advanced memory and analog solutions, today announced it has begun sampling production units of its new 1 Gigabit (1Gb) Low Power (LP) DDR2 products.
Sign-up for ISSI Adds 1Gb Low Power DDR2 DRAM to the Mobile DRAM Product Family investment picks
Achieves Record Revenue of $80.9 Million; Improves Gross Margin 200 Basis Points Sequentially MILPITAS, Calif.
Sign-up for ISSI Announces Second Fiscal Quarter 2014 Results investment picks
MILPITAS, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- Integrated Silicon Solution, Inc. (Nasdaq:ISSI) , a leader in advanced memory and analog solutions, today announced it has begun sampling production units of DRAMs with the highest operating temperature range available in the industry.
Sign-up for ISSI Introduces Industry First 115C Operating Temperature DRAMs investment picks
MILPITAS, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Integrated Silicon Solution, Inc. (Nasdaq:ISSI) , a leader in advanced memory and analog solutions, introduces its new Family of IS25LP- series of Dual Transfer Rate (DTR) flash devices.
Sign-up for ISSI Introduces Industry's Highest-Performance, Wide Voltage, Quad-Interface Dual Transfer Rate (DTR) Serial NOR Flash Memory investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: iRobot To Host Analyst Day to ISSI Introduces Industry's Highest-Performance, Wide Voltage, Quad-Interface Dual Transfer Rate (DTR) Serial NOR Flash Memory
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry